UroGen Pharma (URGN)
Develops localized mitomycin therapies for low-grade urothelial cancers.
$40.47
vs last close−2.29 (−5.36%)
Something off on this page? Send us feedback.
Next report
Nov 5, 26
in 43 days
EPS estimate
$0.10
Revenue estimate
$90.6M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$0.80−$0.92−$1.05−$0.69−$0.54−$0.47−$0.28Pending
Estimate−$0.69−$0.83−$0.82−$0.72−$0.52−$0.56−$0.27$0.10
Surprise−15.9%−10.8%−28.0%+4.2%−4.2%+16.1%−5.7%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$24.6M$20.3M$24.2M$27.5M$37.8M$51.0M$72.5MPending
Estimate$23.3M$23.3M$33.6M$40.1M$39.9M$44.8M$63.5M$90.6M
Surprise+5.2%−12.9%−27.9%−31.5%−5.2%+13.7%+14.0%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2028 | $0.81 | — | — |
| Sep 2028 | $0.81 | — | — |
| Jun 2028 | $0.84 | — | — |
| Mar 2028 | $0.78 | — | — |
| Dec 2027 | $0.68 | — | — |
| Sep 2027 | $0.55 | — | — |
| Jun 2027 | $0.42 | — | — |
| Mar 2027 | $0.31 | — | — |
| Dec 2026 | $0.40 | — | — |
| Nov 2026 | $0.10 | — | — |
| Aug 2026 | −$0.27 | −$0.28 | −5.7% |
| May 2026 | −$0.56 | −$0.47 | +16.1% |
| Mar 2026 | −$0.52 | −$0.54 | −4.2% |
| Nov 2025 | −$0.72 | −$0.69 | +4.2% |
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Feb 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| Mar 2017 | |||
| May 2017 | |||
| Sep 2016 | |||
| Jun 2016 | |||
| Mar 2016 | |||
| Dec 2015 | |||
| Mar 2015 | |||
| Dec 2014 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2028 | $0.81 | — | — | $155.3M | — | — | — |
| Sep 2028 | $0.81 | — | — | $149.4M | — | — | — |
| Jun 2028 | $0.84 | — | — | $149.4M | — | — | — |
| Mar 2028 | $0.78 | — | — | $143.4M | — | — | — |
| Dec 2027 | $0.68 | — | — | $154.9M | — | — | — |
| Sep 2027 | $0.55 | — | — | $141.7M | — | — | — |
| Jun 2027 | $0.42 | — | — | $126.6M | — | — | — |
| Mar 2027 | $0.31 | — | — | $114.9M | — | — | — |
| Dec 2026 | $0.40 | — | — | $108.2M | — | — | — |
| Nov 5, 2026 | $0.10 | — | — | $90.6M | — | — | — |
| Aug 5, 2026 | −$0.27 | −$0.28 | −5.7% | $63.5M | $72.5M | +14.0% | +16.3% |
| May 6, 2026 | −$0.56 | −$0.47 | +16.1% | $44.8M | $51.0M | +13.7% | +10.2% |
| Mar 2, 2026 | −$0.52 | −$0.54 | −4.2% | $39.9M | $37.8M | −5.2% | −12.4% |
| Nov 6, 2025 | −$0.72 | −$0.69 | +4.2% | $40.1M | $27.5M | −31.5% | +21.9% |
| Aug 7, 2025 | |||||||
| May 12, 2025 | |||||||
| Mar 10, 2025 | |||||||
| Nov 6, 2024 | |||||||
| Aug 13, 2024 | |||||||
| May 13, 2024 | |||||||
| Mar 14, 2024 | |||||||
| Nov 14, 2023 | |||||||
| Aug 10, 2023 | |||||||
| May 11, 2023 | |||||||
| Mar 16, 2023 | |||||||
| Nov 10, 2022 | |||||||
| Aug 11, 2022 | |||||||
| May 10, 2022 | |||||||
| Mar 21, 2022 | |||||||
| Nov 15, 2021 | |||||||
| Aug 4, 2021 | |||||||
| May 13, 2021 | |||||||
| Mar 18, 2021 | |||||||
| Nov 9, 2020 | |||||||
| Aug 10, 2020 | |||||||
| May 7, 2020 | |||||||
| Mar 2, 2020 | |||||||
| Nov 12, 2019 | |||||||
| Aug 9, 2019 | |||||||
| May 9, 2019 | |||||||
| Feb 28, 2019 | |||||||
| Nov 12, 2018 | |||||||
| Aug 14, 2018 | |||||||
| May 15, 2018 | |||||||
| Mar 15, 2018 | |||||||
| Nov 14, 2017 | |||||||
| Aug 14, 2017 | |||||||
| Mar 31, 2017 | |||||||
| May 6, 2017 | |||||||
| Sep 30, 2016 | |||||||
| Jun 30, 2016 | |||||||
| Mar 31, 2016 | |||||||
| Dec 31, 2015 | |||||||
| Mar 31, 2015 | |||||||
| Dec 31, 2014 |